These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 19999057)
1. What went wrong? A retrospective on Exubera. Baran MK; Godoy AT Adv Nurse Pract; 2008 Nov; 16(11):53-4, 77. PubMed ID: 19999057 [No Abstract] [Full Text] [Related]
2. Inhaled insulin: new technology, new possibilities. Bellary S; Barnett AH Int J Clin Pract; 2006 Jun; 60(6):728-34. PubMed ID: 16805759 [TBL] [Abstract][Full Text] [Related]
4. [Treatment of patients with diabetes mellitus by means of inhaled insulin]. Simsek S; de Galan BE; Tack CJ; Heine RJ Ned Tijdschr Geneeskd; 2006 Apr; 150(15):829-32. PubMed ID: 16676511 [TBL] [Abstract][Full Text] [Related]
5. The clinical relevance of inhaled insulin in the diabetic lung. Teeter J; Becker R Am J Med; 2006 Feb; 119(2):184-5; author reply 185-6. PubMed ID: 16443436 [No Abstract] [Full Text] [Related]
6. Inhaled insulin--does it become reality? Siekmeier R; Scheuch G J Physiol Pharmacol; 2008 Dec; 59 Suppl 6():81-113. PubMed ID: 19218634 [TBL] [Abstract][Full Text] [Related]
13. Inhaled insulin for the treatment of diabetes mellitus. McAuley L Issues Emerg Health Technol; 2001 Jun; (18):1-4. PubMed ID: 11776284 [TBL] [Abstract][Full Text] [Related]
15. Unlocking the opportunity of tight glycaemic control. Inhaled insulin: clinical efficacy. Scherbaum WA Diabetes Obes Metab; 2005 Nov; 7 Suppl 1():S9-13. PubMed ID: 16135137 [TBL] [Abstract][Full Text] [Related]
16. [Intensive insulin therapy: results after ten years]. Laube H Pharm Unserer Zeit; 2001 Jan; 30(1):40-5. PubMed ID: 11233182 [No Abstract] [Full Text] [Related]
17. [Away with the needle. Noninvasive administration routes for insulin: improved quality of life for diabetics?]. Simon M; Kissel T Pharm Unserer Zeit; 2001; 30(2):136-41. PubMed ID: 11279984 [No Abstract] [Full Text] [Related]
18. An open, randomized, parallel-group study to compare the efficacy and safety profile of inhaled human insulin (Exubera) with glibenclamide as adjunctive therapy in patients with type 2 diabetes poorly controlled on metformin: response to Barnett et al. Kanna B; Abreu-Pacheco H Diabetes Care; 2007 Feb; 30(2):445-6; author reply 446. PubMed ID: 17259531 [No Abstract] [Full Text] [Related]
19. Exit Exubera. Inhalable insulin is withdrawn due to weak sales. Keegan A Diabetes Forecast; 2007 Dec; 60(13):19. PubMed ID: 18217270 [No Abstract] [Full Text] [Related]
20. [Real-world studies for answering real-world questions]. Freemantle N Dtsch Med Wochenschr; 2005 Jul; 130 Suppl 2():S77-81. PubMed ID: 15988673 [No Abstract] [Full Text] [Related] [Next] [New Search]